Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $73.99 -0.04%
Financial Fact:
Cost of goods sold: 7.03M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Cost of goods sold: 7.03M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($1.78). Revenue for the quarter came in at $21.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: U.S. will enforce 'zero leakage' approach to Iran sanctions
- Bessent announces campaign to cut Iran from global economy
- Bessent: we haven't bought a single bond yet, next operation is September 9
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
